His most recent work was in the 17th May issue of the Journal of Medicinal Chemistry published.

It took years of work and evaluation of hundreds of molecules at one with the strength and security, to achieve clinical potential. .. Since 2000, Ghosh to the top of the structure – based design of beta – secreatase inhibitors for therapeutic intervention in Alzheimer’s disease. His most recent work was in the 17th May issue of the Journal of Medicinal Chemistry published. 2007 and also helped in the production of direct CoMentis beta-secretase inhibitor.

CoMentis Inc., a biopharmaceutical company headquartered in San Francisco, is the initiation of clinical trials of the experimental drug CTS-21. Has two appointments in the departments of chemistry and medicinal chemistry is a scientific co-founder of the company with Jordan Tang, the. JG Puterbaugh Chair in Medical Research at the Oklahoma Medical Research Foundation.‘.. The poster be presented: – 29 In October 2009 , 10 – 12 clock – Poster Board: TH-PO615 – lead investigator of: Prof. Angel Luis Mart n de Francisco, University of Cantabria, Santander . – ‘Investment in the CALMAG survey our commitment the best treatment for patients on dialysis emphasizes ‘said Dr. Emanuele Gatti, Chief Executive Officer Fresenius Medical Care is for the regions Europa, Latin America, Middle East and Africa. ‘These results bring us a step closer to our aim an integrated utilities.

Other Posts From Category "urology":

Related Posts